A stem cell epigenome is associated with primary nonresponse to CD19 CAR T cells in pediatric acute lymphoblastic leukemia
Katherine E. Masih(National Institutes of Health), Javed Khan(Kent State University), Yong Kim(National Institutes of Health), Michael C. Jensen(Seattle Children's Hospital), Rimas J. Orentas(Capital Caring), Michael C. Kelly(National Cancer Institute), Serifat Adebola(National Cancer Institute), Martha L. Bulyk(Brigham and Women's Hospital), Ashley Wilson(Center for Infectious Disease Research), Jun S. Wei(Center for Cancer Research), Abdalla Abdelmaksoud(National Cancer Institute), Benjamin Z. Stanton(Nationwide Children's Hospital), Vineela Gangalapudi(National Cancer Institute), David Milewski(National Cancer Institute), Hsien-Chao Chou(National Cancer Institute), Adam Cheuk(National Institutes of Health), Young Song(University of British Columbia), Berkley E. Gryder(University School), Yue Zhang(Southern Medical University), Chaoyu Wang(Chongqing University), Luca Mariani(Brigham and Women's Hospital), Xinyu Wen(National Institutes of Health), Rebecca Gardner(Seattle Children's Hospital), Meijie Tian(National Institutes of Health)
Cited by 18
Related Papers
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
|Nature Medicine|2001|2.7k
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k
The genetic landscape of high-risk neuroblastoma
|Nature Genetics|2013|1.2k